VEGF-production by CCR2-dependent macrophages contributes to laser-induced choroidal neovascularization

Torsten A Krause1, Anne F Alex2, Daniel R Engel1

  • 1Institute of Experimental Immunology, Rheinische Friedrich-Wilhelms-University, Bonn, Germany.

Plos One
|April 10, 2014
PubMed

Insights

In age-related macular degeneration (AMD), CCR2-recruited macrophages transiently increase VEGF in the choroid. However, VEGF-producing microglia dominate later, limiting CCR2-inhibition efficacy for wet AMD treatment.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults.
  • The exudative form of AMD is driven by vascular endothelial growth factor A (VEGF).
  • Mononuclear phagocytes, including macrophages and microglia, are potential VEGF sources, with CCR2 mediating monocyte recruitment.

Purpose of the Study:

  • To investigate the role of macrophages and CCR2 in the pathogenesis of choroidal neovascularization (CNV) in a murine model.
  • To quantify VEGF production by different cell types in the retina and choroid following laser-induced injury.

Main Methods:

  • Establishment of a technique to quantify intracellular VEGF in specific cell subsets from laser-treated murine eyes.
  • Analysis of VEGF content and cell populations in the retina and choroid at different time points post-laser injury.
  • Assessment of neovascularization in CCR2-deficient mice compared to wild-type controls.

Main Results:

  • Macrophage numbers and VEGF content were elevated in the choroid 3 days post-laser, dependent on CCR2-mediated recruitment.
  • Microglia cells were the primary VEGF-producing phagocytes in the retina, with VEGF expression being CCR2-independent.
  • While CCR2-deficient mice showed reduced neovascularization initially, this difference diminished by 3 weeks post-laser.

Conclusions:

  • CCR2-dependent macrophage influx contributes to transient VEGF elevation and early choroidal neovascularization.
  • VEGF production by CCR2-independent cells, particularly microglia, becomes dominant at later stages.
  • Therapeutic strategies targeting CCR2 may have limited long-term efficacy in treating wet AMD due to compensatory VEGF sources.